Princeton, NJ and New York, NY 7/11/17—Alternative investment firm EQT has signed an agreement to acquire Certara for $850 million. Arsenal Capital Partners, the currently owner of Certara, will retain a minority stake. Based in New Jersey, with 500 employees, Certara provides model-informed drug development technology and services, as well as regulatory writing and submission […]